Earnings History Data for Illumina, Inc. (ILMN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Illumina, Inc.

Illumina, Inc. is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Their products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-02-2023	AH	4:05 PM ET (Feb 7)	ILMN	Illumina, Inc.	35,380	0.14	0.26	0.75	Illumina Non-GAAP EPS of $0.14 misses by $0.05, revenue of $1.08B beats by $10M [2/7/2023 4:08 PM]	198.45	-17.29 (-8.01%)	208.24	-7.50 (-3.48%)	173.45 - 371.16	2,141,852	1,040,000	17,292
Illumina faces low-cost rival as BGI touts sub $100 gene sequencing [2/7/2023 10:15 AM] Illumina Non-GAAP EPS of $0.14 misses by $0.05, revenue of $1.08B beats by $10M [2/7/2023 4:08 PM] Illumina in EU hearing to fight order to divest GRAIL [2/8/2023 11:30 AM]
03-11-2022	AH	4:05 PM ET (Nov 3)	ILMN	Illumina, Inc.	34,470	0.34	0.28	1.45	Illumina Non-GAAP EPS of $0.34 beats by $0.04, revenue of $1.12B beats by $10M, lowers FY22 EPS outlook [11/3/2022 4:10 PM]	223.87	11.94 (5.63%)	205.00	-6.93 (-3.27%)	173.45 - 428.00	2,324,535	1,580,000	24,333
Illumina Non-GAAP EPS of $0.34 beats by $0.04, revenue of $1.12B beats by $10M, lowers FY22 EPS outlook [11/3/2022 4:10 PM] Illumina slips as GRAIL impairment prompts guidance cut [11/3/2022 5:00 PM] ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE BOARD OF DIRECTORS [Nov-02-22 10:15AM] Should You Buy Illumina (ILMN) Ahead of Earnings? [Nov-02-22 10:07AM] Why Investors Need to Take Advantage of These 2 Medical Stocks Now [Nov-02-22 09:00AM] Illumina Reports Financial Results for Third Quarter of Fiscal Year 2022 [Nov-03-22 04:05PM] Illumina Introduces New Research Test to Address One of the Most Common Infections in the United States [Nov-03-22 01:10PM] Illumina (ILMN) Surpasses Q3 Earnings and Revenue Estimates [Nov-03-22 05:25PM] Illumina Pummeled On Light Earnings Guidance Despite Quarterly Beat [Nov-03-22 05:20PM]
11-08-2022	AH	4:05 PM ET (Aug 11)	ILMN	Illumina, Inc.	31,690	0.57	0.63	1.87	Illumina GAAP EPS of $0.57 beats by $0.21, revenue of $1.16B misses by $60M, cuts FY22 guidance [8/11/2022 4:06 PM]	208.37	-19.07 (-8.38%)	200.00	-27.44 (-12.06%)	173.45 - 526.00	5,939,794	1,100,000	270,032
Illumina GAAP EPS of $0.57 beats by $0.21, revenue of $1.16B misses by $60M, cuts FY22 guidance [8/11/2022 4:06 PM] Illumina drops 23% as company blames macro factors for Q2 miss [8/11/2022 4:45 PM] Illumina Reports Financial Results for Second Quarter of Fiscal Year 2022 [Aug-11-22 04:05PM] The past year for Illumina (NASDAQ:ILMN) investors has not been profitable [Aug-11-22 10:00AM] Illumina Q2 Preview: 8th Consecutive EPS Beat in Store? [Aug-10-22 05:16PM] How One Children's Hospital Is Transforming Care for Kids in Dubai [Aug-10-22 09:00AM] Illumina (ILMN) Q2 Earnings and Revenues Lag Estimates [Aug-11-22 05:25PM] Illumina stock tanks as gene-sequencing company misses expectations and issues bleak outlook [Aug-11-22 04:49PM]
05-05-2022	AH	4:05 PM ET (May 5)	ILMN	Illumina, Inc.	47,260	1.07	0.87	1.89	Illumina Non-GAAP EPS of $1.07 beats by $0.18, revenue of $1.22B in-line [5/5/2022 4:08 PM]	248.55	-43.17 (-14.80%)	291.00	-0.72 (-0.25%)	239.03 - 526.00	3,375,747	860,000	5,102
Illumina Non-GAAP EPS of $1.07 beats by $0.18, revenue of $1.22B in-line [5/5/2022 4:08 PM] Illumina quarterly net income falls 41% due to GRAIL operating loss [5/5/2022 4:55 PM] Cambridge Launchpad As Illumina Targets Five Million STEM Learners [May-05-22 09:01AM] Illumina and Deerfield Management partner to accelerate drug development [May-05-22 09:15AM] Illumina Reports Financial Results for First Quarter of Fiscal Year 2022 [May-05-22 04:05PM] Illumina Crushes Earnings Forecast, Though Sales Only Meet Expectations [May-05-22 04:20PM] DNA Giant Illumina Smashes Profit Views, Though Sales Just Meet [May-05-22 05:22PM] Illumina (ILMN) Q1 Earnings and Revenues Beat Estimates [May-05-22 05:45PM] Illumina Reports 41% Dip In Q1 Profits Despite 12% Jump in Sales, Reaffirms FY22 Guidance [May-06-22 06:11AM] Cancer Testing Drives Gene-Sequencing Sales at Illumina [May-06-22 10:22AM] Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales [May-06-22 10:58AM] Illumina (ILMN) Q1 Earnings Beat Estimates, Gross Margin Down [May-06-22 10:55AM] 11 Earnings Reports Catching Investors Attention [May-06-22 12:45PM] Illumina ordered to pay BGI subsidiary $333 million in DNA-sequencing patent case [May-06-22 04:46PM] Illumina ordered to pay Chinese company $333 million in gene-sequencing patent case [May-06-22 04:41PM] Stock Market Pares Losses As Nasdaq Falls 1.4%; Jobs Report Offers Mixed Signals [May-06-22 04:34PM]
10-02-2022	AH	4:05 PM ET (Feb 10)	ILMN	Illumina, Inc.	55,450	0.75	0.50	1.22	Illumina Non-GAAP EPS of $0.75 beats by $0.26, revenue of $1.19B beats by $70M [2/10/2022 4:41 PM]	330.90	-27.18 (-7.59%)	342.00	-16.08 (-4.49%)	318.07 - 555.77	1,589,315	870,000	6,663
Illumina Non-GAAP EPS of $0.75 beats by $0.26, revenue of $1.19B beats by $70M [2/10/2022 4:41 PM] Despite 56% drop in net income, Illumina's quarterly results still beat on bottom line [2/10/2022 5:29 PM] Is a Surprise Coming for Illumina (ILMN) This Earnings Season? [Feb-09-22 09:13AM] Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2021 [Feb-10-22 04:05PM] Illuminas Sales Grew, But Biotech Investors Are Hard to Impress [Feb-10-22 05:54PM] Illumina (ILMN) Q4 Earnings and Revenues Beat Estimates [Feb-10-22 05:35PM] Patient Success Story: Beating Stage IV Lung Cancer [Feb-11-22 10:00AM] Illumina (ILMN) Q4 Earnings Top Estimates, Gross Margin Up [Feb-11-22 09:12AM]
04-11-2021	AH	4:05 PM ET (Nov 4)	ILMN	Illumina, Inc.	130,460	1.45	1.24	1.02	Illumina EPS beats by $0.23, beats on revenue [11/4/2021 4:08 PM]	408.70	-13.13 (-3.11%)	421.83	0.0 (0.00%)	292.65 - 555.77	1,404,512	650,000	7,113
Illumina EPS beats by $0.23, beats on revenue [11/4/2021 4:08 PM] Nearly 40% YoY revenue increase in Q3 2021 boosts Illumina's net income [11/4/2021 5:06 PM] Illumina Supports Canada's Nationwide COVID-19 Genome Sequencing Initiative [Nov-03-21 04:05PM] 10 Best Cancer Stocks To Buy Now [Nov-03-21 03:25PM] EXEL vs. ILMN: Which Stock Is the Better Value Option? [Nov-03-21 11:40AM] Illumina Named a World's Top-Female Friendly Company by Forbes [Nov-03-21 08:02AM] What Kind Of Shareholders Own Illumina, Inc. (NASDAQ:ILMN)? [Nov-04-21 10:43AM] After Its Grail Buyout, Illumina Beats Third-Quarter Expectations [Nov-04-21 04:22PM] Illumina Snags Third-Quarter Beat After $7.1 Billion Grail Buyout [Nov-04-21 05:22PM] Illumina (ILMN) Surpasses Q3 Earnings and Revenue Estimates [Nov-04-21 05:45PM] Illumina, inc (ILMN) Q3 2021 Earnings Call Transcript [Nov-04-21 11:02PM] Illumina Reports Financial Results for Third Quarter of Fiscal Year 2021 [Nov-04-21 04:05PM] Illumina (ILMN) Q3 Earnings Top Estimates, 2021 Revenue View Up [Nov-05-21 07:52AM] Illumina Named Best for Vets Employer [Nov-05-21 02:17PM] Illumina Insider Trades $1.2M In Company Stock [Nov-05-21 11:39AM]
05-08-2021	AH	4:05 PM ET (Aug 5)	ILMN	Illumina, Inc.	72,770	1.87	1.36	0.62	Illumina EPS beats by $0.51, beats on revenue; FY21 guidance raised [8/5/2021 4:12 PM]	497.66	-18.02 (-3.49%)	493.50	-22.18 (-4.30%)	260.42 - 555.77	598,159	530,000	5,526
Is Illumina (ILMN) an Interesting Stock to Buy? [Aug-04-21 12:52PM] Drug/Biotech Stocks Q2 Earnings Due on Aug 5: REGN, MRNA, ZTS, ILMN [Aug-04-21 10:39AM] Illumina Stock Dips Late Despite Second-Quarter Beat And Raise [Aug-05-21 04:19PM] Illumina Offers Beat-And-Raise As The Hunt For Covid Variants Intensifies [Aug-05-21 05:08PM] Illumina (ILMN) Beats Q2 Earnings and Revenue Estimates [Aug-05-21 05:25PM] Illumina Reports Financial Results for Second Quarter of Fiscal Year 2021 [Aug-05-21 04:05PM] Illumina, inc (ILMN) Q2 2021 Earnings Call Transcript [Aug-05-21 11:01PM] Illumina (ILMN) Q2 Earnings Top Estimates, 2021 View Up [Aug-06-21 10:07AM] Looking for a Growth Stock? 3 Reasons Why Illumina (ILMN) is a Solid Choice [Aug-06-21 12:45PM]
27-04-2021	AH	4:05 PM ET (Apr 27)	ILMN	Illumina, Inc.	60,580	1.89	1.36	1.64	Illumina EPS beats by $0.50, beats on revenue [4/27/2021 4:08 PM]	405.25	-8.30 (-2.01%)	417.02	3.47 (0.84%)	260.42 - 555.77	759,233	810,000	35,159
Illumina EPS beats by $0.50, beats on revenue [4/27/2021 4:08 PM] Illumina beats consensus with Q1 results as topline growth accelerates [4/27/2021 4:44 PM] Is a Surprise Coming for Illumina (ILMN) This Earnings Season? [Apr-26-21 08:01AM] Illumina Reports Financial Results for First Quarter of Fiscal Year 2021 [Apr-27-21 04:05PM] Illumina Stock Dips Despite First-Quarter Beat, Strong Earnings Guide [Apr-27-21 04:21PM] Illumina Rises On Quarterly Beat, Strong Outlook; Reaffirms Grail Buyout [Apr-27-21 05:37PM] Illumina (ILMN) Q1 Earnings and Revenues Top Estimates [Apr-27-21 05:25PM] Illumina Inc (ILMN) Q1 2021 Earnings Call Transcript [Apr-28-21 12:00AM] How Illumina's Q1 Results Delighted Investors [Apr-28-21 06:04AM] Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative [Apr-28-21 09:05AM] Illumina (ILMN) Q1 Earnings Top Estimates, Margins Decline [Apr-28-21 09:39AM]
11-02-2021	AH	4:05 PM ET (Feb 11)	ILMN	Illumina, Inc.	65,850	1.22	1.21	1.70	Illumina EPS beats by $0.09, beats on revenue [2/11/2021 4:08 PM]	504.41	53.19 (11.79%)	448.00	-3.22 (-0.71%)	196.78 - 555.77	3,181,987	992,713	2,170
Illumina EPS beats by $0.09, beats on revenue [2/11/2021 4:10 PM] Illumina EPS beats by $0.09, beats on revenue [2/11/2021 4:08 PM] Why These 2 Hot Nasdaq Stocks Are Soaring Friday [Feb-12-21 02:52PM] Why Illumina Stock Is Skyrocketing Today [Feb-12-21 12:00PM] Illumina Reports Better-Than-Expected Q4 Earnings; Shares Slip Pre-Market [Feb-12-21 10:27AM] 5 Top Stock Gainers for Friday: Fisker, HubSpot, Illumina [Feb-12-21 07:56AM] Illumina Surges After Strong Earnings, Price Target Upgrades [Feb-12-21 07:36AM] Illumina (ILMN) Q4 Earnings and Revenues Beat Estimates [Feb-11-21 05:35PM] Medical Stock Beats Views, But Shares Dip On Disappointing 2021 Outlook [Feb-11-21 04:56PM] Illumina, Inc. to Host Earnings Call [Feb-11-21 03:15PM]
29-10-2020	AH	4:05 PM ET (Oct 29)	ILMN	Illumina, Inc.	47,090	1.02	0.77	1.93	Illumina EPS beats by $0.22, beats on revenue [10/29/2020 4:12 PM]	292.57	-22.33 (-7.09%)	307.80	-7.10 (-2.26%)	196.78 - 404.20	2,358,204	1,025,702	1,909

06-08-2020	AH	4:05 PM ET (Aug 6)	ILMN	Illumina, Inc.	58,490	0.62	0.72	1.35	Illumina EPS misses by $0.05, misses on revenue [8/6/2020 4:08 PM]	347.81	-51.52 (-12.90%)	350.00	-49.33 (-12.35%)	196.78 - 404.20	2,728,401	695,548	60,719